Minerva Neurosciences NERV
NASDAQ NERV
$2.49 -0.14 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Minerva Neurosciences (NERV) EV to FCF (2017)

Updated

Minerva Neurosciences' EV to FCF came in at 34.36 for Q4 2017, down 34.4% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) EV to FCF (2017) Analysis & Trends

For FY2017, Minerva Neurosciences' EV to FCF was 34.95.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 34.36
Sep 30, 2017 52.39
API Access

Minerva Neurosciences EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=NERV&period=max&api_key=YOUR_API_KEY